Leveraging Multi Omics Platforms for Cancer Immunotherapy

28 Jan 2026
Multi-Omics Integration Stage
  • Deep phenotyping and genotyping of cancer samples from patients to study evolution, treatment resistance, metastasis and biomarkers.  

  • Understanding the complex ways in which cancer biology is underpinned by multi omics.  

  • Capturing cancer evolution and tumour heterogeneity using advanced computational tools 

  • Overview of Manifest – a multi omic platform for cancer immunotherapy. 

Speakers
Samra Turajlic
Samra Turajlic, Group Lead - The Francis Crick Institute